Citations

Citations to this article as recorded by  

• PSP-Richardson syndrome mimics: An overview and pragmatic approach
  J. Necpál, M. Borsek, B. Jeleňová
  Revue Neurologique.2024; 180(1-2): 12.     CrossRef
• Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity
  Yoon A. Kim, Marian Mellen, Caghan Kizil, Ismael Santa‐Maria
  British Journal of Pharmacology.2024; 181(6): 879.     CrossRef
• Concomitant Medications for Progressive Supranuclear Palsy
  Jay M. Iyer, Douglas Gunzler, Anthony E. Lang, Lawrence I. Golbe, Alexander Pantelyat, Adam L. Boxer, Anne-Marie Wills
  JAMA Neurology.2024; 81(3): 295.     CrossRef
• Existing statistical measures and techniques in detecting and evaluating progressive supranuclear palsy, its phenotypes by using MRI modalities: A Review
  Nirmal Adam Sait, J Kathirvelan
  Materials Today: Proceedings.2023; 80: 2000.     CrossRef
• The role of magnetic resonance imaging in the diff erential diagnosis of Parkinson’s disease
  A. A. Tappakhov, T. E. Popova
  Russian neurological journal.2023; 28(1): 5.     CrossRef
• Clinical features of progressive supranuclear palsy
  Yafei Wen, Qijie Yang, Bin Jiao, Weiwei Zhang, Jingyi Lin, Yuan Zhu, Qian Xu, Hui Zhou, Ling Weng, Xinxin Liao, Yafang Zhou, Junling Wang, Jifeng Guo, Xinxiang Yan, Hong Jiang, Beisha Tang, Lu Shen
  Frontiers in Aging Neuroscience.2023;[Epub]     CrossRef
• Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
  Johan Virhammar, Harald Blohmé, Dag Nyholm, Charalampos Georgiopoulos, David Fällmar
  Journal of Neuroimaging.2022; 32(1): 90.     CrossRef
• Cognitive, Psychiatric, and Motor Symptoms–Based Algorithmic Approach to Differentiate Among Various Types of Dementia Syndromes
  Rehab Magdy, Mona Hussein
  Journal of Nervous & Mental Disease.2022; 210(2): 129.     CrossRef
• Idiopathic normal pressure hydrocephalus-like MRI features in patients with progressive supranuclear palsy: a comparative case-control study
  Halil Onder, Bilge Kocer, Selcuk Comoglu
  Neurological Research.2022; 44(9): 807.     CrossRef
• Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders
  M. Lopez-Cuina, W.G. Meissner
  Revue Neurologique.2022; 178(5): 460.     CrossRef
• Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
  Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
  Journal of Clinical Neurology.2022; 18(3): 259.     CrossRef
• Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes
  Qi‐Si Chen, Xin‐Yi Li, Ling Li, Jia‐Ying Lu, Yi‐Min Sun, Feng‐Tao Liu, Chuan‐Tao Zuo, Jian Wang
  Acta Neurologica Scandinavica.2022; 146(3): 237.     CrossRef
• CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
  Kanta Horie, Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Celeste M. Karch, William W. Seeley, Richard J. Perrin, Rama K. Koppisetti, Faris Shaikh, Argentina L
  Nature Medicine.2022; 28(12): 2547.     CrossRef
• Role of Multivoxel MR Spectroscopy Progressive Supranuclear Palsy – A Preliminary Study
  Sandhya Mangalore, Manoj Kumar, Pramod Pal, Jitender Saini, Shaik Pasha, Ravi Yadav
  Neurology India.2022; 70(6): 2388.     CrossRef
• Genetics of Progressive Supranuclear Palsy: A Review
  Yafei Wen, Yafang Zhou, Bin Jiao, Lu Shen
  Journal of Parkinson's Disease.2021; 11(1): 93.     CrossRef
• Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
  John C. Morgan, Xiaolan Ye, Jennifer A. Mellor, Keisha J. Golden, Jorge Zamudio, Louis A. Chiodo, Yanjun Bao, Tao Xie
  Journal of the Neurological Sciences.2021; 421: 117293.     CrossRef
• Central nystagmus in progressive supranuclear palsy: A neglected clinical feature?
  Maja Klarendic, Manja Hribar, Nina Bozanic Urbancic, Nina Zupancic, Milica G. Kramberger, Maja Trost, Saba Battelino, Diego Kaski, Maja Kojovic
  Parkinsonism & Related Disorders.2021; 84: 15.     CrossRef
• Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
  Günter U Höglinger, Irene Litvan, Nuno Mendonca, Deli Wang, Hui Zheng, Beatrice Rendenbach-Mueller, Hoi-Kei Lon, Ziyi Jin, Nahome Fisseha, Kumar Budur, Michael Gold, Davis Ryman, Hana Florian, Anwar Ahmed, Ikuko Aiba, Alberto Albanese, Kelly Bertram, Yvet
  The Lancet Neurology.2021; 20(3): 182.     CrossRef
• A Study on the Essential and Parkinson’s Arm Tremor Classification
  Vasileios Skaramagkas, George Andrikopoulos, Zinovia Kefalopoulou, Panagiotis Polychronopoulos
  Signals.2021; 2(2): 201.     CrossRef
• Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
  Michelle Oyeka, Terngu Ibilah, Jacob Israel, Jose Gavito-Higuera, Ricardo Salazar
  Cureus.2021;[Epub]     CrossRef
• Progressive supranuclear palsy
  N.V. Fedorova, E.V. Bril, T.K. Kulua, A.D. Mikhaylova
  Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2021; 121(5): 111.     CrossRef
• Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
  Brent Bluett, Alexander Y. Pantelyat, Irene Litvan, Farwa Ali, Diana Apetauerova, Danny Bega, Lisa Bloom, James Bower, Adam L. Boxer, Marian L. Dale, Rohit Dhall, Antoine Duquette, Hubert H. Fernandez, Jori E. Fleisher, Murray Grossman, Michael Howell, Di
  Frontiers in Neurology.2021;[Epub]     CrossRef
• The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
  Monica Diez-Fairen, Pilar Alvarez Jerez, Joos Berghausen, Sara Bandres-Ciga
  International Journal of Molecular Sciences.2021; 22(15): 8100.     CrossRef
• MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
  Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Albert H. Kim, Gregory J. Zipfel, Randall J. Bateman, Audrey Gabelle, Nicolas R. Barthélemy
  Annals of Clinical and Translational Neurology.2021; 8(9): 1817.     CrossRef
• “Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism
  Ján Necpál, Miroslav Borsek, Bibiána Jeleňová
  Neurological Sciences.2021; 42(12): 4927.     CrossRef
• Estimation and discussion of prognosis in neurologic practice. Communication issues with patient with neurological disease
  E. V. Bril, A. V. Khasina, F. A. Abbasov, O. S. Zimnyakova, N. V. Fedorova
  Medical alphabet.2021; (22): 55.     CrossRef
• The Progressive Supranuclear Palsy: Past and Present Aspects
  Theodore P. Parthimos, Kleopatra H. Schulpis
  Clinical Gerontologist.2020; 43(2): 155.     CrossRef
• Machine Learning Techniques to Identify Dementia
  Nivedita Manohar Mathkunti, Shanta Rangaswamy
  SN Computer Science.2020;[Epub]     CrossRef
• My dad and progressive supranuclear palsy (PSP)
  Heather Angus-Leppan
  Practical Neurology.2020; 20(3): 263.     CrossRef
• Tauopathy and Movement Disorders—Unveiling the Chameleons and Mimics
  Jacky Ganguly, Mandar Jog
  Frontiers in Neurology.2020;[Epub]     CrossRef
• A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy
  Joanne E. Wittwer, Margaret Winbolt, Meg E. Morris
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy
  Marcos C B Oliveira, Helen Ling, Andrew J Lees, Janice L Holton, Eduardo De Pablo-Fernandez, Thomas T Warner
  Journal of Neurology, Neurosurgery & Psychiatry.2019; 90(5): 555.     CrossRef
• Revisiting the diagnostic value of Evans’ index: lessons from an unusual case of normal pressure hydrocephalus with Evans’ index less than 0.3
  Jung E. Park, Hyunjin Ju, Kayeong Im, Kyum-Yil Kwon
  Neurological Sciences.2019; 40(12): 2637.     CrossRef
• Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly
  Ricardo Fernández-Ferreira, Raúl Anwar García-Santos, Mayela Rodríguez-Violante, Coral López-Martínez, Ivonne Karina Becerra-Laparra, María Eugenia Torres-Pérez
  Revista Española de Geriatría y Gerontología.2019; 54(5): 251.     CrossRef
• Neuroinflammation as a Common Feature of Neurodegenerative Disorders
  Leonardo Guzman-Martinez, Ricardo B. Maccioni, Víctor Andrade, Leonardo Patricio Navarrete, María Gabriela Pastor, Nicolas Ramos-Escobar
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• On the journey to uncover the causes of selective cellular and regional vulnerability in neurodegeneration
  Zane Jaunmuktane, Sebastian Brandner
  Acta Neuropathologica.2019; 138(5): 677.     CrossRef
• Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
  Louise Wiblin, Rory Durcan, Brook Galna, Mark Lee, David Burn
  Journal of Movement Disorders.2019; 12(3): 177.     CrossRef
• Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging
  Yao-Liang Chen, Xiang-An Zhao, Shu-Hang Ng, Chin-Song Lu, Yu-Chun Lin, Jur-Shan Cheng, Chih-Chien Tsai, Jiun-Jie Wang
  Journal of Clinical Medicine.2019; 9(1): 40.     CrossRef
• Tauopathy with hippocampal 4‐repeat tau immunoreactive spherical inclusions: a report of three cases
  Gabor G. Kovacs, Linda K. Kwong, Murray Grossman, David J. Irwin, Edward B. Lee, John L. Robinson, Eunran Suh, Vivianna M. Van Deerlin, Virginia M. Lee, John Q. Trojanowski
  Brain Pathology.2018; 28(2): 274.     CrossRef
• A case of spinal anesthesia in a patient with progressive supranuclear palsy
  Momoka Tonan, Moritoki Egi, Nana Furushima, Satoshi Mizobuchi
  JA Clinical Reports.2018;[Epub]     CrossRef
• Is it Useful to Classify PSP and CBD as Different Disorders? Yes
  Helen Ling, Antonella Macerollo
  Movement Disorders Clinical Practice.2018; 5(2): 145.     CrossRef
• Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes
  Piotr Alster, Ewa Krzyżanowska, Dariusz Koziorowski, Stanisław Szlufik, Dorota Różański, Joanna Noskowska, Justyna Mianowicz, Adrian Michno, Leszek Królicki, Andrzej Friedman
  Neurologia i Neurochirurgia Polska.2018; 52(4): 459.     CrossRef
• Neuro-ophthalmology of movement disorders
  Olga Waln, Joseph Jankovic
  Expert Review of Ophthalmology.2018; 13(5): 283.     CrossRef
• Role of Neuroimaging on Differentiation of Parkinson’s Disease and Its Related Diseases
  Toshihide Ogawa, Shinya Fujii, Keita Kuya, Shin-ichiro Kitao, Yuki Shinohara, Mana Ishibashi, Yoshio Tanabe
  Yonago Acta Medica.2018; 61(3): 145.     CrossRef
• Gait disorders in adults and the elderly
  Walter Pirker, Regina Katzenschlager
  Wiener klinische Wochenschrift.2017; 129(3-4): 81.     CrossRef
• Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease
  Steve Vucic, Matthew C. Kiernan
  Neurotherapeutics.2017; 14(1): 91.     CrossRef
• Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
  Adam L Boxer, Jin-Tai Yu, Lawrence I Golbe, Irene Litvan, Anthony E Lang, Günter U Höglinger
  The Lancet Neurology.2017; 16(7): 552.     CrossRef

Citations

Citations to this article as recorded by  

• Aggregation-Induced Emission Luminogens: A New Possibility for Efficient Visualization of RNA in Plants
  Zheng-Chao Yang, Li-Xiang Zhao, Yu-Qi Sang, Xin Huang, Xuan-Chen Lin, Zhi-Ming Yu
  Plants.2024; 13(5): 743.     CrossRef
• Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
  Jacqui T. Nimmo, Harry Smith, Chang Yi Wang, Jessica L. Teeling, James A. R. Nicoll, Ajay Verma, Jean-Cosme Dodart, Zhi Liu, Feng Lin, Roxana O. Carare
  Acta Neuropathologica.2022; 143(1): 55.     CrossRef
• Autophagy-Related Pathways in Vesicular Unconventional Protein Secretion
  Shin Hye Noh, Ye Jin Kim, Min Goo Lee
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
  Irene Sanchez-Mirasierra, Saurav Ghimire, Sergio Hernandez-Diaz, Sandra-Fausia Soukup
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson’s disease: application to preladenant
  Rachel Rose, Emma Mitchell, Piet Van Der Graaf, Daisuke Takaichi, Jun Hosogi, Hugo Geerts
  Journal of Pharmacokinetics and Pharmacodynamics.2022; 49(6): 593.     CrossRef
• Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
  Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia, Anupom Borah, Xin Wang, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya
  Immunology.2021; 162(2): 160.     CrossRef
• Electrogastrography for diagnosis of early-stage Parkinson's disease
  Nobuyuki Araki, Yoshitaka Yamanaka, Anupama Poudel, Yoshikatsu Fujinuma, Akira Katagiri, Satoshi Kuwabara, Masato Asahina
  Parkinsonism & Related Disorders.2021; 86: 61.     CrossRef
• Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
  Simona S. Ghanem, Hend S. Fayed, Qi Zhu, Jia-Hong Lu, Nishant N. Vaikath, Janarthanan Ponraj, Said Mansour, Omar M. A. El-Agnaf
  Molecules.2021; 26(12): 3736.     CrossRef
• Tat-p27 Ameliorates Neuronal Damage Reducing α-Synuclein and Inflammatory Responses in Motor Neurons After Spinal Cord Ischemia
  Woosuk Kim, Hyun Jung Kwon, Hyo Young Jung, Kyu Ri Hahn, Seung Myung Moon, Yeo Sung Yoon, In Koo Hwang, Soo Young Choi, Dae Won Kim
  Neurochemical Research.2021; 46(12): 3123.     CrossRef
• Immunotherapies for Parkinson’s Disease: Progression of Clinical Development
  Jet Shee Teng, Yin Yin Ooi, Soi Moi Chye, Anna Pick Kiong Ling, Rhun Yian Koh
  CNS & Neurological Disorders - Drug Targets.2021; 20(9): 802.     CrossRef
• Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
  Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, Ted M. Dawson, Eric Barker
  Pharmacological Reviews.2021; 73(4): 1204.     CrossRef
• Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
  Khalil Mallah, Christine Couch, Davis M. Borucki, Amer Toutonji, Mohammed Alshareef, Stephen Tomlinson
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
  Miguel Lemos, Serena Venezia, Violetta Refolo, Antonio Heras-Garvin, Sabine Schmidhuber, Armin Giese, Andrei Leonov, Sergey Ryazanov, Christian Griesinger, Gergana Galabova, Guenther Staffler, Gregor Karl Wenning, Nadia Stefanova
  Translational Neurodegeneration.2020;[Epub]     CrossRef
• Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
  James H. Torpey, Richard M. Meade, Ravina Mistry, Jody M. Mason, Jillian Madine
  Frontiers in Neuroscience.2020;[Epub]     CrossRef
• Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
  Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
  Alzheimer's Research & Therapy.2020;[Epub]     CrossRef
• Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
  Khosro Jamebozorgi, Eskandar Taghizadeh, Daryoush Rostami, Hosein Pormasoumi, George E. Barreto, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar
  Molecular Neurobiology.2019; 56(7): 4799.     CrossRef
• The Associations between Immunological Reactivity to the Haptenation of Unconjugated Bisphenol A to Albumin and Protein Disulfide Isomerase with Alpha-Synuclein Antibodies
  Datis Kharrazian, Martha Herbert, Aristo Vojdani
  Toxics.2019; 7(2): 26.     CrossRef
• Effects of single and combined immunotherapy approach targeting amyloid β protein and α‐synuclein in a dementia with Lewy bodies–like model
  Markus Mandler, Edward Rockenstein, Cassia Overk, Michael Mante, Jazmin Florio, Anthony Adame, Changyoun Kim, Radmila Santic, Achim Schneeberger, Frank Mattner, Sabine Schmidhuber, Gergana Galabova, Brian Spencer, Eliezer Masliah, Robert A. Rissman
  Alzheimer's & Dementia.2019; 15(9): 1133.     CrossRef
• Translational therapies for multiple system atrophy: Bottlenecks and future directions
  Nadia Stefanova
  Autonomic Neuroscience.2018; 211: 7.     CrossRef
• Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
  Liyan Hou, Xiuqi Bao, Caixia Zang, Hanyu Yang, Fuqiang Sun, Yuning Che, Xuefei Wu, Shao Li, Dan Zhang, Qingshan Wang
  Redox Biology.2018; 14: 600.     CrossRef
• Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
  Isabell Kuhn, Tobias Rogosch, Theresa I. Schindler, Björn Tackenberg, Michael Zemlin, Rolf F. Maier, Richard Dodel, Yannick Kronimus
  Journal of Neuroimmunology.2018; 315: 33.     CrossRef
• Beneficial Effects of Flavonoids Against Parkinson's Disease
  Un Ju Jung, Sang Ryong Kim
  Journal of Medicinal Food.2018; 21(5): 421.     CrossRef
• Unconventional protein secretion – new insights into the pathogenesis and therapeutic targets of human diseases
  Jiyoon Kim, Heon Yung Gee, Min Goo Lee
  Journal of Cell Science.2018;[Epub]     CrossRef
• Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
  Martin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, Fredrik Eriksson, Jessica Sigvardson, Werner Poewe, Gregor K. Wenning, Eva Nordström, Nadia Stefanova
  Frontiers in Neuroscience.2018;[Epub]     CrossRef
• Gene therapy for neurological disorders: progress and prospects
  Benjamin E. Deverman, Bernard M. Ravina, Krystof S. Bankiewicz, Steven M. Paul, Dinah W. Y. Sah
  Nature Reviews Drug Discovery.2018; 17(9): 641.     CrossRef
• Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies
  Edward Rockenstein, Gary Ostroff, Fusun Dikengil, Florentina Rus, Michael Mante, Jazmin Florio, Anthony Adame, Ivy Trinh, Changyoun Kim, Cassia Overk, Eliezer Masliah, Robert A. Rissman
  The Journal of Neuroscience.2018; 38(4): 1000.     CrossRef
• Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
  Julianna J. Tomlinson, Bojan Shutinoski, Li Dong, Fanyi Meng, Dina Elleithy, Nathalie A. Lengacher, Angela P. Nguyen, Greg O. Cron, Qiubo Jiang, Erik D. Roberson, Robert L. Nussbaum, Nour K. Majbour, Omar M. El-Agnaf, Steffany A. Bennett, Diane C. Lagace,
  Journal of Neural Transmission.2017; 124(6): 721.     CrossRef
• Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
  Xiaoli Si, Jiali Pu, Baorong Zhang
  Journal of Movement Disorders.2017; 10(2): 69.     CrossRef
• Membrane Trafficking Illuminates a Path to Parkinson’s Disease
  Takafumi Hasegawa, Naoto Sugeno, Akio Kikuchi, Toru Baba, Masashi Aoki
  The Tohoku Journal of Experimental Medicine.2017; 242(1): 63.     CrossRef
• Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
  J. Teister, F. Anders, S. Beck, S. Funke, H. von Pein, V. Prokosch, N. Pfeiffer, F. Grus
  Scientific Reports.2017;[Epub]     CrossRef
• Impact of aging immune system on neurodegeneration and potential immunotherapies
  Zhanfeng Liang, Yang Zhao, Linhui Ruan, Linnan Zhu, Kunlin Jin, Qichuan Zhuge, Dong-Ming Su, Yong Zhao
  Progress in Neurobiology.2017; 157: 2.     CrossRef
• A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
  Jess-Karan S. Dhillon, Cara Riffe, Brenda D. Moore, Yong Ran, Paramita Chakrabarty, Todd E. Golde, Benoit I. Giasson, Stephan N. Witt
  PLOS ONE.2017; 12(9): e0184731.     CrossRef
• Vaccination strategies in tauopathies and synucleinopathies
  Anne K. Braczynski, Jörg B. Schulz, Jan‐Philipp Bach
  Journal of Neurochemistry.2017; 143(5): 467.     CrossRef
• Missions of <italic>Journal of Movement Disorders</italic>
  Yun Joong Kim
  Journal of Movement Disorders.2016; 9(1): 1.     CrossRef
• How strong is the evidence that Parkinson's disease is a prion disorder?
  Patrik Brundin, Jiyan Ma, Jeffrey H. Kordower
  Current Opinion in Neurology.2016; 29(4): 459.     CrossRef

Citations

Citations to this article as recorded by  

• Typical pantothenate kinase-associated neurodegeneration caused by compound heterozygous mutations in PANK2 gene in a Chinese patient: a case report and literature review
  Yilun Tao, Chen Zhao, Dong Han, Yiju Wei, Lihong Wang, Wenxia Song, Xiaoze Li
  Frontiers in Neurology.2023;[Epub]     CrossRef
• The first Vietnamese patient who presented late onset of pantothenate kinase-associated neurodegeneration diagnosed by whole exome sequencing: A case report
  Van Khanh Tran, Chi Dung Vu, Hai Anh Tran, Nguyen Thi Kim Lien, Nguyen Van Tung, Nguyen Ngoc Lan, Huy Thinh Tran, Nguyen Huy Hoang
  Medicine.2023; 102(43): e34853.     CrossRef
• Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
  Dahae Yang, Sanghyun Cho, Sung Im Cho, Manjin Kim, Moon-Woo Seong, Sung Sup Park
  Orphanet Journal of Rare Diseases.2022;[Epub]     CrossRef
• Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia
  Kyung Ah Woo, Han-Joon Kim, Seung-Ho Jeon, Hye Ran Park, Kye Won Park, Seung Hyun Lee, Sun Ju Chung, Jong-Hee Chae, Sun Ha Paek, Beomseok Jeon
  Journal of Movement Disorders.2022; 15(3): 241.     CrossRef
• Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome
  Luz María González Huerta, Sorina Gómez González, Jaime Toral López
  Psychiatric Genetics.2021; 31(3): 95.     CrossRef
• Rational Design of Novel Therapies for Pantothenate Kinase–Associated Neurodegeneration
  Nivedita Thakur, Thomas Klopstock, Suzanne Jackowski, Enej Kuscer, Fernando Tricta, Aleksandar Videnovic, Hyder A. Jinnah
  Movement Disorders.2021; 36(9): 2005.     CrossRef
• Atypical Pantothenate Kinase-Associated Neurodegeneration with variable phenotypes in an Egyptian family
  Ali S. Shalash, Thomas W. Rösler, Ibrahim Y. Abdelrahman, Hatem S. Abulmakarem, Stefanie H. Müller, Franziska Hopfner, Gregor Kuhlenbäumer, Günter U. Höglinger, Mohamed Salama
  Heliyon.2021; : e07469.     CrossRef
• Treatment Responsiveness of Parkinsonism in Atypical Pantothenate Kinase‐Associated Neurodegeneration
  Jeanne Feuerstein, Caroline Olvera, Michelle Fullard
  Movement Disorders Clinical Practice.2020;[Epub]     CrossRef
• Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
  Randall D. Marshall, Abigail Collins, Maria L. Escolar, H. A. Jinnah, Thomas Klopstock, Michael C. Kruer, Aleksandar Videnovic, Amy Robichaux-Viehoever, Colleen Burns, Laura L. Swett, Dennis A. Revicki, Randall H. Bender, William R. Lenderking
  Orphanet Journal of Rare Diseases.2019;[Epub]     CrossRef
• Intrafamilial variability and clinical heterogeneity in a family with PLA2G6-associated neurodegeneration
  Jong Kyu Park, Jinyoung Youn, Jin Whan Cho
  Precision and Future Medicine.2019; 3(3): 135.     CrossRef
• On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation
  C. Tello, A. Darling, V. Lupo, B. Pérez‐Dueñas, C. Espinós
  Clinical Genetics.2018; 93(4): 731.     CrossRef
• Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase–Associated Neurodegeneration
  J.-H. Lee, A. Gregory, P. Hogarth, C. Rogers, S.J. Hayflick
  American Journal of Neuroradiology.2018; 39(3): 583.     CrossRef
• Parkinson’s Disease and Metal Storage Disorders: A Systematic Review
  Edward Botsford, Jayan George, Ellen Buckley
  Brain Sciences.2018; 8(11): 194.     CrossRef
• Atypical pantothenate kinase-associated neurodegeneration: Clinical description of two brothers and a review of the literature
  S. Mahoui, A. Benhaddadi, W. Ameur El Khedoud, M. Abada Bendib, M. Chaouch
  Revue Neurologique.2017; 173(10): 658.     CrossRef
• Clinical rating scale for pantothenate kinase‐associated neurodegeneration: A pilot study
  Alejandra Darling, Cristina Tello, María Josep Martí, Cristina Garrido, Sergio Aguilera‐Albesa, Miguel Tomás Vila, Itziar Gastón, Marcos Madruga, Luis González Gutiérrez, Julio Ramos Lizana, Montserrat Pujol, Tania Gavilán Iglesias, Kylee Tustin, Jean Pie
  Movement Disorders.2017; 32(11): 1620.     CrossRef
• Missions of <italic>Journal of Movement Disorders</italic>
  Yun Joong Kim
  Journal of Movement Disorders.2016; 9(1): 1.     CrossRef

Citations

Citations to this article as recorded by  

• A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis
  Diana Apetauerova, Peter Hildebrand, Stephanie Scala, Janet W. Zani, LeeAnne Lipert, Erin Clark, Tanya Fennell, Fredric D. Gordon
  Hepatology Communications.2021; 5(2): 323.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease
  Ryoji Naganuma, Ichiro Yabe, Megumi Takeuchi, Kirari Morishita, Shingo Nakane, Ryoken Takase, Ikuko Takahashi-Iwata, Masaaki Matsushima, Mika Otsuki, Hideaki Shiraishi, Hidenao Sasaki, Wing-ho Yung
  PLOS ONE.2020; 15(9): e0232808.     CrossRef
• Short-Term Effects of Thoracic Spine Manipulation on the Biomechanical Organisation of Gait Initiation: A Randomized Pilot Study
  Sébastien Ditcharles, Eric Yiou, Arnaud Delafontaine, Alain Hamaoui
  Frontiers in Human Neuroscience.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Impact of galvanic vestibular stimulation electrode current density on brain current flow patterns: Does electrode size matter?
  Dennis Q. Truong, Alexander Guillen, Mujda Nooristani, Maxime Maheu, Francois Champoux, Abhishek Datta, Mohammad Ali Salehinejad
  PLOS ONE.2023; 18(2): e0273883.     CrossRef
• The Effectiveness of Electrical Vestibular Stimulation (VeNS) on Symptoms of Anxiety: Study Protocol of a Randomized, Double-Blinded, Sham-Controlled Trial
  Teris Cheung, Joyce Yuen Ting Lam, Kwan Hin Fong, Yuen Shan Ho, Alex Ho, Calvin Pak-Wing Cheng, Julie Sittlington, Yu-Tao Xiang, Tim Man Ho Li
  International Journal of Environmental Research and Public Health.2023; 20(5): 4218.     CrossRef
• Acceptability and feasibility of a vestibular nerve stimulation headset protocol in children with cerebral palsy
  Karen McConnell, Daniel Topley, Jason McKeown, Claire Kerr
  BMC Pediatrics.2022;[Epub]     CrossRef
• Effect of galvanic vestibular stimulation on axial symptoms in Parkinson’s disease
  Hiroshi Kataoka, Yohei Okada, Takao Kiriyama, Yorihiro Kita, Junji Nakamura, Koji Shomoto, Kazuma Sugie
  Journal of Central Nervous System Disease.2022; 14: 117957352210815.     CrossRef
• Galvanic vestibular stimulation and its applications: a systematic review
  Anna Paula Batista de Ávila Pires, Tatiana Rocha Silva, Maíra Soares Torres, Maria Luiza Diniz, Maurício Campelo Tavares, Denise Utsch Gonçalves
  Brazilian Journal of Otorhinolaryngology.2022; 88: S202.     CrossRef
• Detection and assessment of Parkinson's disease based on gait analysis: A survey
  Yao Guo, Jianxin Yang, Yuxuan Liu, Xun Chen, Guang-Zhong Yang
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• EFFECT OF VESTIBULAR STIMULATION ON BEHAVIORAL CHANGES IN PARKINSON DISEASE-INDUCED MICE
  Ram Mohan, Mohan Jayabal, Rashmi Ramanathan, Jeevithan Shanmugam, Archana R
  Asian Journal of Pharmaceutical and Clinical Research.2022; : 84.     CrossRef
• IMPACT OF CALORIC VESTIBULAR STIMULATION ON CO-ORDINATION IN PARKINSON DISEASE INDUCED MICE
  RAM MOHAN, KAYALVIZHI, RASHMI RAMANATHAN, JEEVITHAN SHANMUGAM, ARCHANA R.
  International Journal of Pharmacy and Pharmaceutical Sciences.2022; : 46.     CrossRef
• The effect of galvanic vestibular stimulation on postural balance in Parkinson's disease: A systematic review and meta-analysis
  Mohammad Mahmud, Zaeem Hadi, Mabel Prendergast, Matteo Ciocca, Abdel Rahman Saad, Yuscah Pondeca, Yen Tai, Gregory Scott, Barry M. Seemungal
  Journal of the Neurological Sciences.2022; 442: 120414.     CrossRef
• A systematic review of vestibular stimulation in cerebral palsy
  Daniel Topley, Karen McConnell, Claire Kerr
  Disability and Rehabilitation.2021; 43(23): 3291.     CrossRef
• The link between lateral trunk flexion in Parkinson’s disease and vestibular dysfunction: a clinical study
  Haiyan Tang, You Chen, Zhidong Cen, Zhiyuan Ouyang, Danning Lou, Ying Tan, Wei Luo
  International Journal of Neuroscience.2021; 131(6): 521.     CrossRef
• Vestibular stimulation: a noninvasive brain stimulation in Parkinson’s disease & its implications
  Thanalakshmi Jagadeesan, Archana Rajagopal, Senthilkumar Sivanesan
  Journal of Complementary and Integrative Medicine.2021; 18(4): 657.     CrossRef
• Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease
  Soojin Lee, Aiping Liu, Martin J. McKeown
  Expert Review of Neurotherapeutics.2021; 21(4): 405.     CrossRef
• Caloric and galvanic vestibular stimulation for the treatment of Parkinson’s disease: rationale and prospects
  David Wilkinson
  Expert Review of Medical Devices.2021; 18(7): 649.     CrossRef
• Early balance impairment in Parkinson’s Disease: Evidence from Robot-assisted axial rotations
  Alessandro Zampogna, Ilaria Mileti, Francesca Martelli, Marco Paoloni, Zaccaria Del Prete, Eduardo Palermo, Antonio Suppa
  Clinical Neurophysiology.2021; 132(10): 2422.     CrossRef
• Dizziness in Parkinson’s disease patients is associated with vestibular function
  Jeong-Ho Park, Suk Yun Kang
  Scientific Reports.2021;[Epub]     CrossRef
• c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats
  Ghazaleh Samoudi, Andrea Nilsson, Thomas Carlsson, Filip Bergquist
  Neuroscience.2020; 424: 146.     CrossRef
• Sensory Neuromodulation
  Robert D. Black, Lesco L. Rogers
  Frontiers in Systems Neuroscience.2020;[Epub]     CrossRef
• Efficacy of transmastoidal galvanic stimulation on recovery outcomes in patients with unilateral peripheral vestibular disorders: a randomized controlled trial
  Reham Ali Mohamed Ali Ahmed, Ebtesam Mohamed Fahmy, Amina Mohamed Awad, Mona Mohamed Hamdy, Hussein Ahmed Abd Rahman Shaker
  The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2020;[Epub]     CrossRef
• Effect of caloric vestibular stimulation on brain neurochemicals in rotenone induced mouse model of Parkinson’s disease
  Sai Sailesh Kumar G, Srilatha Bashetti
  International Journal of Clinical Biochemistry and Research.2020; 7(1): 49.     CrossRef
• The Effect of L-dopa on Postural Stability in Parkinson’s Disease Patients
  Jacek Wilczyński, Natalia Habik
  Applied Sciences.2019; 9(3): 409.     CrossRef
• Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
  Fabio Bello, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia
  Biomolecules.2019; 9(4): 142.     CrossRef
• Aplicações dos potenciais evocados miogênicos vestibulares: revisão sistemática de literatura
  Tatiana Rocha Silva, Marco Aurélio Rocha Santos, Luciana Macedo de Resende, Ludimila Labanca, Júlia Fonseca de Morais Caporali, Marjore Rhaissa de Sousa, Denise Utsch Gonçalves
  Audiology - Communication Research.2019;[Epub]     CrossRef
• Caloric vestibular stimulation for the management of motor and non-motor symptoms in Parkinson's disease
  David Wilkinson, Aleksandra Podlewska, Sarah E. Banducci, Tracy Pellat-Higgins, Martin Slade, Mayur Bodani, Mohamed Sakel, Lanty Smith, Peter LeWitt, Kristen K. Ade
  Parkinsonism & Related Disorders.2019; 65: 261.     CrossRef
• Deterioration of postural deformity in Parkinson’s disease patients with punding and hobbyism
  Ryoma Aoki, Makoto Shiraishi, Kyohei Mikami, Tsutomu Kamo
  Journal of Clinical Neuroscience.2019; 69: 179.     CrossRef
• Recent advancements in lateral trunk flexion in Parkinson disease
  Hiroshi Kataoka, Kazuma Sugie
  Neurology Clinical Practice.2019; 9(1): 74.     CrossRef
• Galvanic Vestibular Stimulation (GVS) Augments Deficient Pedunculopontine Nucleus (PPN) Connectivity in Mild Parkinson's Disease: fMRI Effects of Different Stimuli
  Jiayue Cai, Soojin Lee, Fang Ba, Saurabh Garg, Laura J. Kim, Aiping Liu, Diana Kim, Z. Jane Wang, Martin J. McKeown
  Frontiers in Neuroscience.2018;[Epub]     CrossRef
• Effects of Galvanic Vestibular Stimulation on Upper and Lower Extremities Motor Symptoms in Parkinson’s Disease
  Mahta Khoshnam, Daniela M. C. Häner, Eunice Kuatsjah, Xin Zhang, Carlo Menon
  Frontiers in Neuroscience.2018;[Epub]     CrossRef
• Vestibular Functions and Parkinson's Disease
  Paul F. Smith
  Frontiers in Neurology.2018;[Epub]     CrossRef
• Body Posture, Postural Stability, and Metabolic Age in Patients with Parkinson’s Disease
  Jacek Wilczyński, Agnieszka Pedrycz, Dariusz Mucha, Tadeusz Ambroży, Dawid Mucha
  BioMed Research International.2017; 2017: 1.     CrossRef
• Vestibular Deficits in Neurodegenerative Disorders: Balance, Dizziness, and Spatial Disorientation
  Thomas Cronin, Qadeer Arshad, Barry M. Seemungal
  Frontiers in Neurology.2017;[Epub]     CrossRef
• Vestibular neuromodulation: stimulating the neural crossroads of psychiatric illness
  Steven M Miller
  Bipolar Disorders.2016; 18(6): 539.     CrossRef
• Non-Invasive Neuromodulation Using Time-Varying Caloric Vestibular Stimulation
  Robert D. Black, Lesco L. Rogers, Kristen K. Ade, Heather A. Nicoletto, Heather D. Adkins, Daniel T. Laskowitz
  IEEE Journal of Translational Engineering in Health and Medicine.2016; 4: 1.     CrossRef

Citations

Citations to this article as recorded by  

• Paravertebral Muscle Mechanical Properties and Spinal Range of Motion in Patients with Acute Neck or Low Back Pain: A Case-Control Study
  Sandra Alcaraz-Clariana, Lourdes García-Luque, Juan Luis Garrido-Castro, César Fernández-de-las-Peñas, Cristina Carmona-Pérez, Daiana Priscila Rodrigues-de-Souza, Francisco Alburquerque-Sendín
  Diagnostics.2021; 11(2): 352.     CrossRef
• Paravertebral Muscle Mechanical Properties in Patients with Axial Spondyloarthritis or Low Back Pain: A Case-Control Study
  Sandra Alcaraz-Clariana, Lourdes García-Luque, Juan Luis Garrido-Castro, I. Concepción Aranda-Valera, Lourdes Ladehesa-Pineda, María Ángeles Puche-Larrubia, Cristina Carmona-Pérez, Daiana Priscila Rodrigues-de-Souza, Francisco Alburquerque-Sendín
  Diagnostics.2021; 11(10): 1898.     CrossRef

Citations

Citations to this article as recorded by  

• Transient Hemichorea-hemiballism Induced by a Combination of Postprandial Hypotension and Severe Stenosis of the Innominate Artery Concomitant with Left Carotid Occlusion
  Sho Okune, Mikito Hayakawa, Tenyu Hino, Takato Hiramine, Taisuke Akimoto, Masayuki Sato, Yoshiro Ito, Aiki Marushima, Tomoya Takada, Eiichi Ishikawa, Akira Tamaoka, Yuji Matsumaru
  Internal Medicine.2024; 63(4): 577.     CrossRef
• Spicy foods triggering clinical symptoms in Moyamoya angiopathy
  Souvik DUBEY, Ritwik GHOSH, Subhankar CHATTERJEE, Mahua J. DUBEY, Biman K. RAY, Shambaditya DAS, Apratim CHATTERJEE, Durjoy LAHIRI, Markus KRAEMER
  Journal of Neurosurgical Sciences.2021;[Epub]     CrossRef
• Corticostriatal Hypermetabolism in Moyamoya Disease-Induced Hemichorea: Two Case Reports and a Literature Review
  Wen-biao Xian, Xiang-song Zhang, Xin-chong Shi, Gan-hua Luo, Chang Yi, Zhong Pei
  Frontiers in Neurology.2021;[Epub]     CrossRef
• Transient Ischemic Attack after Eating Spicy Foods in Children: Think of Moya Moya Disease
  Thomas Mathew, DelonD Souza, SajiK John, GG Sharath Kumar
  Neurology India.2021; 69(4): 1032.     CrossRef
• Asymmetric lenticulostriate arteries in patients with moyamoya disease presenting with movement disorder: three new cases
  Jiali Xu, Sijie Li, Gary B. Rajah, Wenbo Zhao, Changhong Ren, Yuchuan Ding, Qian Zhang, Xunming Ji
  Neurological Research.2020; 42(8): 665.     CrossRef
• Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis
  Do-Young Kwon
  Journal of Movement Disorders.2016; 9(2): 63.     CrossRef